One Wall Street Analyst Sees More than 400% Upside in SpaceX Stock. Why I'm Still Not Buying.

Raymond James initiated coverage of Space Exploration Technologies (SpaceX) with a “strong buy” rating and an $800 price target, arguing Starship could enable new industries with 2031 revenue of $837B and $696B EBITDA. The article pushes back that the $800 target is speculative versus current fundamentals (about $19B revenue last year and an operating loss) and highlights execution/regulatory/economic hurdles for near-term concepts like sub-hour cargo, space AI data centers, and asteroid mining. It also notes potential downside risk from multiple lock-up expirations that could increase share supply, implying shares could be lower over the next year.

Analysis

This is less a valuation upgrade than a signal that the market is being asked to price a decade of optionality as if it were near-term equity cash flow. The real risk is that headline-grabbing targets create a temporary bid, but post-IPO supply and insider selling windows turn that bid into liquidity for pre-existing holders. In the first few days the move can extend on narrative alone; over 1-3 months the setup is more about float absorption than model revisions.

The only economically relevant near-term asset is the recurring connectivity franchise, and that is exactly where competitive pressure is most likely to show up first. If pricing power weakens or churn rises, the market will not wait for the grander space-economy story; it will compress multiples across the entire high-duration satellite/launch complex. The second-order loser is the crowded growth basket that trades on optionality rather than realized cash flow.

The contrarian miss is that the upside path depends on several sequential veto points: repeatable launch cadence, regulatory clearance, ground infrastructure, and monetizable demand. Any slippage on one of those steps pushes the thesis out by years, not quarters. Falsifiers are concrete: evidence of routine reuse/cadence, meaningful customer contracts tied to launch economics, and lock-up periods passing without persistent supply pressure.

Key Decisions for Investors

• Do not chase SPCX on the initial analyst hype; if you have private/secondary exposure, use strength into upcoming lock-up windows to trim 25-50% and reassess after supply clears.
• Short RKLB on any sympathy rally tied to renewed space optimism; 1-3 month thesis is multiple compression if the market starts discounting narrative-heavy space names again. Cover if Starship shows repeatable reuse and cadence.
• If you want a cleaner hedge, buy 2-4 month puts on a public space-beta proxy into catalyst windows rather than paying up for outright downside in SPCX; structure the trade for limited premium at risk.
• Set an alert for operational proof, not commentary: if Starship reaches consistent launch/reuse cadence or if visible commercial contracts appear, the short thesis weakens materially and should be reduced.